More than 74,000 participants in clinical trials lost their access to care as a result of Trump administration cuts to the National Institutes of Health. File Photo by Annabelle Gordon/UPI | License Photo
Thousands of clinical trial participants lost access to important medical studies this year after the Trump administration terminated hundreds of National Institutes of Health grants, new research published in JAMA Internal Medicine indicates.
The study found that 383 clinical trials had their NIH funding cut this year between late February and August, affecting more than 74,000 participants nationwide.
Many of the canceled studies focused on infectious diseases, including HIV and COVID-19, as well as mental health and cancer.
For researchers like Amy Nunn and Dr. Philip Chan at the Rhode Island Public Health Institute, the cuts brought their work to an immediate stop.
